Infection Medicine (BMC)
221 – 230 of 1822
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort
(
- Contribution to journal › Article
-
Mark
Intensive care patients with preeclampsia – Clinical risk factors and biomarkers for oxidative stress and angiogenic imbalance as discriminators for severe disease
(
- Contribution to journal › Article
-
Mark
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
(
- Contribution to journal › Article
-
Mark
Get the Species Right : Aerococcus viridans is Likely not Responsible
(
- Contribution to journal › Letter
-
Mark
Interactions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusions : a protocol for a simulation study
(
- Contribution to journal › Article
-
Mark
Epidemiology, aetiology and clinical characteristics of clostridial bacteraemia : a 6-year population-based observational study of 386 patients
(
- Contribution to journal › Article
-
Mark
Hierarchical Clustering and Trajectory Analyses Reveal Viremia-Independent B-Cell Perturbations in HIV-2 Infection
(
- Contribution to journal › Article
-
Mark
One Scoring System Does Not Fit All Healthcare Settings
2022) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(1). p.166-167(
- Contribution to journal › Letter
-
Mark
Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019 : a retrospective analysis
(
- Contribution to journal › Article
-
Mark
Reply to Rezahosseini
2022) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(12). p.2262-2262(
- Contribution to journal › Debate/Note/Editorial